The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

An intensive blood pressure reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and older with untreated hypertension.

Hyperactivation of certain brain regions in children and adolescents with ARFID suggest a new neurobiological circuit associated with the disorder.

Metabolic syndrome (MetS) and its individual components are associated with an increased risk for young-onset dementia (YOD).

The prevalence of depression among adolescents and adults aged 12 years and older during 2021 to 2023 had a 60% increase from 2013 to 2014.

HealthDay News — Patients with heart failure experience worsening neuropsychological outcomes over six months, according to a study published online April 8 in Advances in Clinical and Experimental ...

More than 40% of US adults know someone who died by suicide and 5.3% reported suicidal thoughts during the previous 12 months.

The FDA has granted Orphan Drug designation to BA-102 for the treatment of Phelan-McDermid syndrome, a rare neurodevelopmental disorder.

Recent onset of schizophrenia or other primary psychotic disorders may need intensive support for lives disrupted by their diagnosis.

HealthDay News — Dementia biomarkers — phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) — are associated with age, sex, and apolipoprotein E ( APOE) ...

Maternal report of infant temperament and developmental milestones at 9 months of age may be associated with early indicators of autism likelihood at 12 months.

Postpartum sleep in first-time Black mothers may be impacted due to racial discrimination and financial strain, beyond their infant’s sleep patterns.